You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Ginkgo Biloba Extract and Long-Term Cognitive Decline: A 20-Year Follow-Up Population-Based Study
|
---|---|
Published in |
PLOS ONE, January 2013
|
DOI | 10.1371/journal.pone.0052755 |
Pubmed ID | |
Authors |
Hélène Amieva, Céline Meillon, Catherine Helmer, Pascale Barberger-Gateau, Jean François Dartigues |
Abstract |
Numerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on age-related cognitive decline often leading to inconclusive results due to small sample sizes or insufficient follow-up duration. The present study assesses the association between intake of EGb761® and cognitive function of elderly adults over a 20-year period. |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 21% |
Australia | 4 | 17% |
Canada | 2 | 8% |
Germany | 1 | 4% |
Netherlands | 1 | 4% |
Italy | 1 | 4% |
Ireland | 1 | 4% |
United Kingdom | 1 | 4% |
Unknown | 8 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 19 | 79% |
Practitioners (doctors, other healthcare professionals) | 2 | 8% |
Scientists | 2 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Israel | 1 | <1% |
Slovakia | 1 | <1% |
Canada | 1 | <1% |
Switzerland | 1 | <1% |
Unknown | 120 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 30 | 24% |
Student > Master | 17 | 14% |
Researcher | 13 | 10% |
Other | 11 | 9% |
Student > Ph. D. Student | 9 | 7% |
Other | 21 | 17% |
Unknown | 23 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 23 | 19% |
Agricultural and Biological Sciences | 16 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 9% |
Nursing and Health Professions | 10 | 8% |
Psychology | 9 | 7% |
Other | 26 | 21% |
Unknown | 29 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#1,282,385
of 25,654,806 outputs
Outputs from PLOS ONE
#16,095
of 223,967 outputs
Outputs of similar age
#10,773
of 291,470 outputs
Outputs of similar age from PLOS ONE
#319
of 4,956 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 223,967 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,470 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 4,956 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.